Advanced search
Publication Cover
Cancer Biology & Therapy Volume 23, 2022 - Issue 1
Submit an article Journal homepage
7,100
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis

Zibo Chena Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;b Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USAView further author information
,
Lin Zhenga Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Yulong Chena Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Xiuxia Liub Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USAView further author information
,
Masanori Kawakamia Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;b Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USAView further author information
,
Lisa Maria Mustachioa Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Jason Roszikc Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;d Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-4561-6170View further author information
ORCID Icon,
Katherine V. Ferry-Galowe Clinical Pharmacodynamic Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USAView further author information
,
Ralph E. Parchmente Clinical Pharmacodynamic Program, Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USAView further author information
,
Xin Liua Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Thorkell Andressonb Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USAView further author information
,
Gerard Duncanb Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USAView further author information
,
Jonathan M. Kuriea Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Jaime Rodriguez-Canalesf Oncology and Translational Medicine, AstraZeneca, Gaithersburg, MD, USAView further author information
,
Xi Liua Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;b Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USAView further author information
&
Ethan Dmitrovskya Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;b Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA;g Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
 show all
Pages 265-280 | Received 17 Aug 2021, Accepted 21 Feb 2022, Published online: 07 Apr 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.